Hepatitis C elimination in Myanmar: Modelling the impact, cost, cost-effectiveness and economic benefits

BACKGROUND: Myanmar has set national hepatitis C (HCV) targets to achieve 50% of people diagnosed and 50% treated by 2030. The WHO has additional targets of reducing incidence by 80% and mortality by 65% by 2030. We aimed to estimate the impact, cost, cost-effectiveness and net economic benefit of a...

Descripción completa

Detalles Bibliográficos
Autores principales: Scott, Nick, Win, Thin Mar, Tidhar, Tom, Htay, Hla, Draper, Bridget, Aung, Phyo Thu Zar, Xiao, Yinzong, Bowring, Anna, Kuschel, Christian, Shilton, Sonjelle, Kyi, Khin Pyone, Naing, Win, Aung, Khin Sanda, Hellard, Margaret
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8315611/
https://www.ncbi.nlm.nih.gov/pubmed/34327345
http://dx.doi.org/10.1016/j.lanwpc.2021.100129

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8315611/
https://www.ncbi.nlm.nih.gov/pubmed/34327345
http://dx.doi.org/10.1016/j.lanwpc.2021.100129

Ejemplares similares